News Search

Search results for:

Montreal Heart Institute pilots Steriwave

Second Quebec-based hospital pilots nasal photodisinfection to reduce antibiotic resistance   Vancouver, British Columbia, Canada - September 21, 2023 The world-renowned Montreal Heart Institute and Hôpital Fleurimont, University of Sherbrooke (CHUS) in Sherbrooke, Quebec are piloting nasal photodisinfection to prevent post-operative infections in an era [...]

Steriwave proven highly effective against XDR bacteria

Ondine Biomedical presents research demonstrating high efficacy against Extensively Drug-Resistant (XDR) bacteria at ICPIC 2023, Geneva   Vancouver, British Columbia, Canada - September 14, 2023 Canadian life sciences company Ondine Biomedical Inc. (LON: OBI) has presented new research at the 2023 International Consortium on Prevention & [...]

BBC News features first NHS pilot of Steriwave

BBC Look North evening news feature: A pioneering laser treatment which could cut the risk of drug-resistant infections after operations is being trialled for the first time in the UK. A six-month NHS pilot will see 500 patients given Ondine Biomedical's Steriwave® nasal photodisinfection at Pontefract Hospital in [...]

August 9, 2023|Tags: , , , |

Bloomberg articles: Killing Bugs in the Nose

Bloomberg publishes articles on Steriwave™ nasal photodisinfection International - February 24, 2023 Today, Bloomberg published an article in both its newsletter and in Businessweek about Ondine Biomedical’s Steriwave™ nasal photodisinfection:   Newsletter: Killing Bugs in the Nose Businessweek: Germ-Zapping Lasers Help Cut Down on Infections [...]

February 24, 2023|Tags: , , , , |

Ondine receives funding for meat photodisinfection

Ondine Biomedical receives Agriculture and Agri-Food Canada (AAFC) funding to improve food security and increase shelf-life through photodisinfection Vancouver, British Columbia, Canada - December 5, 2022 Funding of up to $735,000 towards development of prototype of novel photodisinfection application for use in food production. Up [...]

December 5, 2022|Tags: , , , |

Ondine reports full results from Phase 2 nasal photodisinfection trial

Ondine Biomedical reports the full results from Phase 2 nasal photodisinfection trial  Vancouver, British Columbia, Canada - December 5, 2022 Full results confirm that a single, 5-minute treatment of nasal photodisinfection significantly reduces Staphylococcus aureus, a major cause of surgical site infections, in pre-surgical patients.   [...]

Ondine cuts COVID-19 rate in food processing plant

Food processing plant sees huge reduction in employee COVID-19 rates after using nasal photodisinfection New research suggests that nasal photodisinfection could significantly reduce employee COVID-19 positive rates at food processing facilities Vancouver, British Columbia, Canada - November 7, 2022 Research presented last week at [...]

November 8, 2022|Tags: , , |

Ondine’s President and CTO receives IPA Lifetime Achievement Award

Ondine’s Dr. Nicolas Loebel receives IPA Lifetime Achievement Award for photodisinfection advancements Vancouver, British Columbia, Canada - October 31, 2022 Nicolas Loebel, Nicolas Loebel, President &Chief Technology Officer at Ondine Biomedical Inc. Dr. Nicolas Loebel, President and Chief Technology officer of Ondine Biomedical [...]

October 31, 2022|Tags: , , |

For Media Information

Simon Vane Percy

Amanda Bernard

Go to Top